Gütersloh Plus
Essen und Trinken in Gütersloh
Gütersloh News und Nachrichten
Gütsel Data (Contentstatistik)
Gütsel Marketing Service (GMS)
[…] Nordisk A/S, Share repurchase programme Bagsværd, Denmark, 10 January 2022On 5 November 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period […] weiterlesen …
[…] Nordisk A/S, Share repurchase programme Bagsværd, Denmark, 17 January 2022On 5 November 2021, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period […] weiterlesen …
[…] Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons Bagsværd, Denmark, 4 February 2022This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. Members of Executive Management have participated in a long-term incentive programme consisting of a one-year […] weiterlesen …
[…] Nordisk – major shareholder announcement Bagsværd, Denmark, 14 February 2022Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) that Blackrock as of 8 February 2022 holds B shares equal to 5. 05% of the entire share capital of Novo Nordisk. The announcement is in accordance with section 30 of the Danish Capital Markets Act. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to […] weiterlesen …
[…] Launches AI That Can FlirtSonantic, a leader in hyper-realistic text-to-speech technology, demonstrates groundbreaking advancements in emotional speech synthesis with amorous AI video. “What’s Her Secret?” London, England, February 14, 2022Sonantic, a leader in developing fully expressive AI-generated voice software for film and gaming studios, has produced a video in collaboration with a Hollywood client entitled “What’s Her Secret?” The video surprises viewers when it’s revealed […] weiterlesen …
[…] Nordisk A/S: Share repurchase programme Bagsværd, Denmark, 21 February 2022On 2 February 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 22 billion to be executed during a 12-month period […] weiterlesen …
[…] Nordisk expands research collaboration in novel delivery technologies for biologic medicines Bagsværd, Denmark, 9 March 2022Novo Nordisk today announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital (BWH). Since 2015, scientists from Novo Nordisk and the laboratories of Prof. Giovanni Traverso and Prof. Robert Langer have explored novel technologies as alternatives […] weiterlesen …
[…] Nordisk – major shareholder announcement Bagsværd, Denmark, 14 March 2022Novo Nordisk today announced that the company has been notified by BlackRock, Inc. (Blackrock) that Blackrock as of 8 March 2022 holds B shares equal to below 5% of the entire share capital of Novo Nordisk. The announcement is in accordance with section 30 of the Danish Capital Markets Act. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section […] weiterlesen …
[…] University Hospital signs Memorandum of Understanding with Major Academic Medical Center in the United States Karolinska University Hospital has signed a Memorandum of Understanding (MOU) with Brigham and Women’s Hospital, which is located in Boston, Massachusetts to Explore Potential for Scientific, Educational, and Cultural Collaboration. Through this MOU, Karolinska University Hospital will work closely with Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School, to […] weiterlesen …
[…] bleeding after giving birth is globally a leading cause of death in new mothers [1] Bagsværd, Denmark, 22 April 2022Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending an extension of the Novo Seven (eptacog alfa) label to include treatment of women suffering from severe haemorrhage after giving birth, when medications used to induce uterine contractions and reduce bleeding […] weiterlesen …
[…] Novo Nordisk A/S, Share Repurchase Programme Bagsværd, Denmark, 16 May 2022On 3 May 2022, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Rules”). This programme is part of the overall share repurchase programme of up to DKK 24 billion to be executed during a 12-month period […] weiterlesen …
[…] Nordisk achieves primary objectives of Onwards 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in Onwards 1 Bagsværd, Denmark, 3 June 2022Novo Nordisk today announced headline results from the main phases of Onwards 1 (52 weeks) and Onwards 6 (26 weeks) phase 3a trials with once-weekly insulin icodec. Onwards 1 (insulin naïve people with type 2 diabetes) Onwards 1 is a phase 3a, 78-week efficacy and safety treat-to-target trial […] weiterlesen …
[…] Novo Nordisk—major shareholder announcement Bagsværd, Denmark, 7 June 2022Novo Nordisk today announced that the company has been notified by Black Rock, Inc. (Blackrock) that Blackrock as of 31 May 2022 holds B shares equal to below 5 percent of the entire share capital of Novo Nordisk. The announcement is in accordance with section 30 of the Danish Capital Markets Act. The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to […] weiterlesen …
[…] Officially Launches Its Full Range of Products in Spain Yadea officially announced its expansion into the Spanish market after the world’s leading electric two-wheeler brand held a successful high-profile launch event at Madrid City Hall on June 21. Yadea held a launch event at Madrid City Hall to announce its expansion into the Spanish market “With our expansion into this new market, we are delighted to bring even more green mobility solutions to the people of Spain”, said Yadea Europe […] weiterlesen …
[…] for leukaemia patients through discovery at Karolinska University Hospital In a recently published study, Nikolas Herold and Martin Jädersten from Karolinska University Hospital show how acute myeloid leukaemia can be treated more effectively. They have reused an already proven medicinal product. Acute myeloid leukaemia (AML) is an aggressive blood cancer with a high mortality that affects about 350 people annually in Sweden. Over 70 percent of patients die within five years of falling ill […] weiterlesen …
[…] May, Jane Goodall, Diane Ackerman and the NASA Communications Unit Announced as Winners of the Stephen Hawking Medal at Starmus VI ArmeniaBrian May wins Stephen Hawking Medal Yerevan, Armenia, September 6th, 2022Some of the most influential names in science, music and arts have been named as the latest Laureates of the Stephen Hawking Medal for Science Communication at Starmus VI festival. The winners are Diane Ackerman, poet and essayist; Dr. Jane Goodall, DBE, Founder of the Jane Goodall […] weiterlesen …
[…] University Hospital ranks 9 in Newsweek’s survey “World’s Best Smart Hospitals 2023” For the second year, Newsweek has produced a list of the hospitals that makes the best use of the most advanced technology in healthcare. The survey ranks the leaders in the use of artificial intelligence (AI), digital imaging, telemedicine, robotics, and electronic functionality. Karolinska, which is the only hospital outside the USA on the top 10 list among the “World’s Best Smart Hospitals” […] weiterlesen …
[…] insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in Onwards 5 phase 3a trial Bagsværd, Denmark, 3rd October 2022Novo Nordisk today announced headline results from the Onwards 5 phase 3a trial with once-weekly insulin icodec in people with type 2 diabetes. The Onwards 5 trial was a 52-week, open-label efficacy and safety treat-to-target trial investigating once-weekly insulin versus […] weiterlesen …
[…] Nordisk A/S, Share repurchase programme Bagsværd, Denmark, November 4th, 2022The execution of Novo Nordisk A/S’ overall share repurchase programme for 2022 of DKK 24 billion continues. As part of this, Novo Nordisk A/S has now initiated a new share repurchase programme of up to DKK 3. 8 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe […] weiterlesen …
[…] Nordisk invests DKK 5. 4 bn Danish kroner in expansion of clinical manufacturing facilities in Bagsværd, Denmark Bagsværd, Denmark, November 22nd, 2022Novo Nordisk today announced plans to invest 5. 4 bn Danish kroner in the expansion of existing facilities in Bagsværd. The plans also include the construction of a new plant located in extension of the existing facilities. The investment will establish additional capacity in R & D for manufacturing of active pharmaceutical ingredients […] weiterlesen …
[…] Awards Pontosense for Outstanding Achievement in Wireless SensingToronto, December 19th, 2022Pontosense, a leader in wireless sensing, is proud to announce that the IEEE has selected its Wireless Intelligent Sensing (WISe) solution for its HITC Award for Excellence in Hyper-Intelligence (Industrial Impact Award). This award recognizes the revolutionary innovation in wireless vitals sensing and hyper-intelligent systems. This honor recognizes Pontosense's extraordinary contributions to […] weiterlesen …
[…] Alienware Revamps its Iconic Laptop Armada at CES 2023Round Rock, Texas, Dell Technologies, January 3rd, 2023Alienware and Dell today reveal six new gaming laptops including: Alienware m18 and m16, Alienware x16 and x14, and Dell G16 and G15. And these aren’t small updates either—the roster debuts updated form factors and materials, best-in-class performance upgrades, design and comfort enhancements, as well as an overhauled Alienware Command Center. As what defines preeminent gaming […] weiterlesen …
[…] and Novo Nordisk announce first patient dosed in clinical study with HS-001—a cell therapy designed to restore heart function in people with advanced heart failure HS 001 consists of clusters of purified heart muscle cells derived from induced pluripotent stem cells (iPSCs). Clinical phase 1/2 study (LAPiS Study) will enrol 10 patients with advanced heart failure caused by ischaemic heart disease. Tokyo, Japan, Bagsværd, Denmark, February 10th, 2023Heartseed Inc. (Heartseed) and Novo Nordisk […] weiterlesen …
[…] Nordisk to Expand R & D Presence in Greater Boston Area Bagsværd, Denmark, March 2nd, 2023Novo Nordisk just announced plans to expand its research and development (R & D) presence in the greater Boston metro area, creating one of its largest R & D hubs outside of Denmark. This new hub, which will leverage the company’s existing presence in Lexington, Cambridge and Watertown, Massachusetts, will be home to the majority of Novo Nordisk’s US-based research and development […] weiterlesen …
[…] ranks Karolinska University Hospital as the world’s sixth best hospital With a nr six ranking, Karolinska University Hospital reaches its highest result yet in Newsweek Magazine’s ranking ”World´s Best Hospitals 2023”. Karolinska is ranked highest of all European hospitals. Newsweek’s assessment encompasses more than 2 300 hospitals in 28 countries. The ranking is based on four aspects:Recommendations from a large number of experts in the health care sector, such as physicians and […] weiterlesen …
